HIV-associated tuberculosis in the era of highly active antiretroviral therapy

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 11, 2000, Pages 1026-1031

  Jones, J L ^a   Hanson, D L ^a   Dworkin, M S ^a   DeCock, K M ^a   Thompsom, M ^a   Grochowski, K ^a   Cohn, D ^a   Davidson, A ^a   Rietmeijer, C ^a   Sorvillo, F ^a   Masters, D ^a   Wotring, L ^a   Mokotoff, E ^a   Sackoff, J ^a   McFarland, J ^a   Miranda, S ^a   Otero, J ^a   Hunter, R ^a   Gomez, M ^a   Buskin, S ^a   Hopkins, S ^a   Odem, S ^a   Melville, S ^a   NcNelly, W ^a   Reynolds, K ^a   Morse, A ^a   Troxler, S ^a   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

AIDS; Antiretroviral therapy; HIV; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HUMANS; MALE; RISK FACTORS; TUBERCULOSIS; UNITED STATES;

EID: 0033757450     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection
2. Tuberculosis morbidity - United States, 1992
3. Trends in opportunistic infections among men who have sex with men and among injecting drug users, 1991-1996
4. Trends in drug-resistant tuberculosis in the United States, 1993-1996
5. The impact of human immunodeficiency virus infection on drug-resistant tuberculosis
6. The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA
7. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter
8. Delta: A randomized doubleblind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals
9. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
10. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
11. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration
12. Update trends in AIDS incidence, deaths, and prevalence - United States, 1996
13. Update trends in AIDS incidence - United States, 1996
14. HIV/AIDS Surveillance Report
15. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
16. Case definitions for infectious conditions under public health surveillance
17. Spectrum of disease in persons with human immunodeficiency virus infection in the United States
18. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
19. Prevention treatment of tuberculosis among patients infected with human immunodeficiency virus: Principles of therapy revised recommendations
20. The fall after the rise: Tuberculosis in the United States, 1991 through 1994
21. Tuberculosis in New York City - Turning the tide
22. Risk factors for developing active tuberculosis among HIV-infected PPD-positive patients
23. The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993
24. Tuberculosis among AIDS patients in the United States, 1993
25. How important is race/ethnicity as an indicator of risk for specific AIDS-defining conditions